BCAX - Bicara Therapeutics

-

$undefined

N/A

(N/A)

Bicara Therapeutics :BCAX Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The company's dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy.

Location: Cambridge, Massachusetts, United States | Website: https://www.bicara.com | Industry: | Sector:


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

189.7M

Cash

203.9M

Avg Qtr Burn

-11.52M

Short % of Float

-

Insider Ownership

6.96%

Institutional Own.

31.66%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date